198 related articles for article (PubMed ID: 14636558)
1. Neutrophil elastase cleaves PML-RARalpha and is important for the development of acute promyelocytic leukemia in mice.
Lane AA; Ley TJ
Cell; 2003 Oct; 115(3):305-18. PubMed ID: 14636558
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil elastase is important for PML-retinoic acid receptor alpha activities in early myeloid cells.
Lane AA; Ley TJ
Mol Cell Biol; 2005 Jan; 25(1):23-33. PubMed ID: 15601827
[TBL] [Abstract][Full Text] [Related]
3. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.
Kelly LM; Kutok JL; Williams IR; Boulton CL; Amaral SM; Curley DP; Ley TJ; Gilliland DG
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8283-8. PubMed ID: 12060771
[TBL] [Abstract][Full Text] [Related]
4. A protease-resistant PML-RAR{alpha} has increased leukemogenic potential in a murine model of acute promyelocytic leukemia.
Uy GL; Lane AA; Welch JS; Grieselhuber NR; Payton JE; Ley TJ
Blood; 2010 Nov; 116(18):3604-10. PubMed ID: 20647568
[TBL] [Abstract][Full Text] [Related]
5. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice.
Zimonjic DB; Pollock JL; Westervelt P; Popescu NC; Ley TJ
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13306-11. PubMed ID: 11087871
[TBL] [Abstract][Full Text] [Related]
6. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
Lo-Coco F; Hasan SK
Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
[TBL] [Abstract][Full Text] [Related]
7. High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression.
Westervelt P; Lane AA; Pollock JL; Oldfather K; Holt MS; Zimonjic DB; Popescu NC; DiPersio JF; Ley TJ
Blood; 2003 Sep; 102(5):1857-65. PubMed ID: 12750176
[TBL] [Abstract][Full Text] [Related]
8. Expression of the promyelocytic leukemia protein without the nuclear localization signal as a novel diagnostic marker for acute promyelocytic leukemia.
Xu T; Yang XQ; Jiang KL; Wang H; Ma PP; Zhong L; Liu BZ
Oncol Rep; 2017 Feb; 37(2):986-994. PubMed ID: 28075463
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752
[TBL] [Abstract][Full Text] [Related]
10. A bcr-3 isoform of RARalpha-PML potentiates the development of PML-RARalpha-driven acute promyelocytic leukemia.
Pollock JL; Westervelt P; Kurichety AK; Pelicci PG; Grisolano JL; Ley TJ
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15103-8. PubMed ID: 10611345
[TBL] [Abstract][Full Text] [Related]
11. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARα and inhibits the growth of acute promyelocytic leukemia.
Guo Y; Dolinko AV; Chinyengetere F; Stanton B; Bomberger JM; Demidenko E; Zhou DC; Gallagher R; Ma T; Galimberti F; Liu X; Sekula D; Freemantle S; Dmitrovsky E
Cancer Res; 2010 Dec; 70(23):9875-85. PubMed ID: 20935222
[TBL] [Abstract][Full Text] [Related]
13. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.
He LZ; Tribioli C; Rivi R; Peruzzi D; Pelicci PG; Soares V; Cattoretti G; Pandolfi PP
Proc Natl Acad Sci U S A; 1997 May; 94(10):5302-7. PubMed ID: 9144232
[TBL] [Abstract][Full Text] [Related]
14. PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells.
Fu S; Consoli U; Hanania EG; Zu Z; Claxton DF; Andreeff M; Deisseroth AB
Clin Cancer Res; 1995 Jun; 1(6):583-90. PubMed ID: 9816019
[TBL] [Abstract][Full Text] [Related]
15. The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.
Jing Y
Leuk Lymphoma; 2004 Apr; 45(4):639-48. PubMed ID: 15160934
[TBL] [Abstract][Full Text] [Related]
16. Two critical hits for promyelocytic leukemia.
He LZ; Bhaumik M; Tribioli C; Rego EM; Ivins S; Zelent A; Pandolfi PP
Mol Cell; 2000 Nov; 6(5):1131-41. PubMed ID: 11106752
[TBL] [Abstract][Full Text] [Related]
17. PML-RARα stabilized by zinc in human acute promyelocytic leukemia NB4 cells.
Zhu B; Wang JY; Zhou JJ; Zhou F; Cheng W; Liu YT; Wang J; Chen X; Chen DH; Luo L; Hua ZC
J Inorg Biochem; 2017 Oct; 175():92-100. PubMed ID: 28743050
[TBL] [Abstract][Full Text] [Related]
18. Asynchronous expression of myeloid antigens in leukemic cells in a PML/RARalpha transgenic mouse model.
Santana BA; Pintão MC; Abreu e Lima RS; Scheucher PS; Santos GA; Garcia AB; Falcão RP; Rego EM
Braz J Med Biol Res; 2006 May; 39(5):615-20. PubMed ID: 16648899
[TBL] [Abstract][Full Text] [Related]
19. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.
Walter MJ; Park JS; Ries RE; Lau SK; McLellan M; Jaeger S; Wilson RK; Mardis ER; Ley TJ
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12513-8. PubMed ID: 16113082
[TBL] [Abstract][Full Text] [Related]
20. Targeting PML/RARalpha transcript with DNAzymes results in reduction of proliferation and induction of apoptosis in APL cells.
Kabuli M; Yin JA; Tobal K
Hematol J; 2004; 5(5):426-33. PubMed ID: 15448669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
